Clinical Trials Browser

Phase 2 × Dehydroepiandrosterone × Breast × Clear all

NCT04493333 2024-11-27

Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors

Phase 2 Terminated

8 enrolled 11 charts

Vaginal Atrophy